Pluristem Therapeutics Inc.
Pluristem is a clinical-stage regenerative medicine company using placental cells and a 3D technology platform to develop cell therapies and cultivated meat products.
Product News
Product Areas
Cellular Agriculture | ||
| Cells lines | Show all suppliers | |
advertisement
advertisement
Get our eNewsletter
Get our eNewsletter and keep up-to-date with the latest protein sources for food processors - subscribe now !
LATEST NEWS
- Carbery and Synergy Join EIT Food to Accelerate Innovation in Sustainable Nutrition
- MycoTechnology’s ClearHT™ Natural Flavor Modifier Achieves FEMA GRAS Status
- IFF Unveils Cutting-Edge Citrus Innovation Center in Florida
- Cultivated Biosciences Rebrand to Cosaic and Introduce Cosaic Neo
- The European Bio-tech Company Nasekomo Report a Record Feed Conversion Ratio
- ACI Group Launches Innovative Plant-based Protein Line
- Corbion Launches Innovative Egg Replacers to Empower Bakeries Amid Supply Challenges
- New Solutions for Conventional Meat and Plant-based Market
- GNT Advances CO2 Reduction Goals in Latest Sustainability Report
- Epax Launches First Commercially Available VLC-PUFA Product
EVENTS
- Farmed Insect Protein Sector Conference
- IFFA 2025 Technology for Meat and Alternative Proteins
- Vitafoods Europe
- Future Food-Tech Sustainable Proteins & Ingredients
- Bridge2Food EUROPE 2025
- 23rd Annual Food Innovate Summit
- Free-from, Functional and Health Ingredients Expo
- 5th International Food Innovation Conference
- IFT FIRST Annual Event and Expo
- future food-tech